Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
10.14
-0.10 (-0.98%)
At close: Nov 22, 2024, 4:00 PM
10.21
+0.07 (0.69%)
After-hours: Nov 22, 2024, 7:43 PM EST

Arcutis Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Market Capitalization
1,1873059011,0431,225-
Upgrade
Market Cap Growth
232.05%-66.18%-13.58%-14.88%--
Upgrade
Enterprise Value
1,0642836266811,039-
Upgrade
Last Close Price
10.143.2314.8020.7428.13-
Upgrade
PS Ratio
8.265.11244.56---
Upgrade
PB Ratio
7.573.444.303.504.53-
Upgrade
P/TBV Ratio
7.403.714.453.504.53-
Upgrade
EV/Sales Ratio
7.674.74169.88---
Upgrade
Debt / Equity Ratio
1.332.320.970.260.020.00
Upgrade
Asset Turnover
0.380.150.01---
Upgrade
Inventory Turnover
1.040.48----
Upgrade
Quick Ratio
2.276.3811.0611.6112.6119.36
Upgrade
Current Ratio
2.467.0811.5712.0912.9620.33
Upgrade
Return on Equity (ROE)
-192.31%-175.79%-122.80%-72.62%-72.93%-56.10%
Upgrade
Return on Assets (ROA)
-31.14%-38.12%-43.97%-36.54%-42.15%-34.10%
Upgrade
Return on Capital (ROIC)
-36.88%-42.65%-47.89%-39.67%-45.26%-35.94%
Upgrade
Earnings Yield
-16.48%-85.99%-34.55%-19.78%-11.07%-
Upgrade
FCF Yield
-14.14%-81.18%-28.63%-16.84%-9.25%-
Upgrade
Buyback Yield / Dilution
-84.05%-25.94%-11.39%-38.51%-1835.11%-48.68%
Upgrade
Total Shareholder Return
-84.05%-25.94%-11.39%-38.51%-1835.11%-48.68%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.